Categories: Business

Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life

SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ — Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third iteration of the innovative device delivers significant enhancements, including an extended shelf life, improved ease of use, and streamlined preparation, directly addressing critical feedback from physician users.

- Advertisement -

The highly anticipated Sniper G3 features a 24-month shelf life, doubling the longevity of its predecessor. This improvement offers greater inventory flexibility for hospitals and clinics. Designed with direct input from interventional radiologists, Sniper G3 also features improved trackability and a simplified preparation process, significantly reducing pre-procedure setup time. The new prep method eliminates several steps, cutting preparation time down to less than a minute, a crucial gain in fast-paced clinical environments. This focus on user feedback underscores Embolx’s commitment to developing intuitive, high-performance tools that enhance clinical workflow.

- Advertisement -

Sniper G3 truly exemplifies our dedication to innovation driven by physician needs,” said Michael Allen, President and CEO of Embolx. “We listened intently to our users and engineered a device that not only extends product longevity and improves performance, but also significantly enhances the ease of use, which translates directly to more efficient procedures. We are incredibly proud of Sniper G3 and its potential to set a new standard in embolization therapy.”

The Sniper G3 Balloon Occlusion Microcatheter represents a significant leap forward in Embolx’s commitment to physician-centric innovation. It is available in all standard lengths and is ready for worldwide distribution.

- Advertisement -

About Embolx
Embolx has pioneered advanced pressure-mediated delivery of therapeutics directly into cancerous tumors, prostates, and other anatomical structures and is dedicated to transforming healthcare through the development of innovative technologies.

- Advertisement -

For media inquiries, please contact:

Haley McGregor
Global Marketing and Sales Operations Manager
hmcgregor@embolx.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/2738641/Sniper_g3_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/embolx-launches-sniper-g3-revolutionizing-embolization-with-enhanced-efficiency-ease-of-use-and-extended-shelf-life-302514310.html

PRNW Agency

Recent Posts

Italian Leading Fashion Group OVS to open its store in New Delhi

~The store opens at Pacific Mall, Tagore Garden, West Delhi's shopping hub~ NEW DELHI, Sept.…

17 minutes ago

Independent Commission Against Corruption (ICAC) exchanges MoU with Hungarian Integrity Authority at B&R Summit to strengthen anti-corruption cooperation

HONG KONG, Sept. 12, 2025 /PRNewswire/ -- ICAC Commissioner, Mr Woo Ying-ming, exchanged a Memorandum…

18 minutes ago

TARIFF FEARS DRIVE U.S. STOCKPILING IN AUGUST, WHILE MANUFACTURING WEAKENS IN EUROPE AND ASIA: GEP SUPPLY CHAIN VOLATILITY INDEX

North America's supply chains get busier, with sharp stockpiling of components to guard against tariff-driven…

18 minutes ago

The Avestagenome Project and ‘Longevity India’ Initiative of Indian Institute of Science (IISc) Sign Landmark Agreement

To Advance Scientific Research in Aging, Longevity and Precision Healthcare BENGALURU, India, Sept. 9, 2025…

19 minutes ago

CAS introduces CAS IP Finder for improved intellectual property search

The AI-enhanced solution deepens search capabilities and improves user experience  COLUMBUS, Ohio, Sept. 9, 2025…

19 minutes ago

Deepscent AI Submitted to CES 2026 Innovation Awards in Four Categories

SEOUL, South Korea--(BUSINESS WIRE)--#AI--Deepscent Inc., a South Korean IT company specializing in digital olfactory solutions,…

7 hours ago